19 November 2025
19 November 2025
CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.
The approval follows evaluation of data from the Phase III Aspen and Phase II Willow studies.
At two upcoming events, experts will offer practical solutions to key challenges for oncology and rare disease clinical trials.
Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into opportunities.
Genprex is advancing additional applications in Canada, China, Brazil, Europe and Israel.
In a year where ADC deals have showed no signs of slowing, Solve has become the latest biotech to unlock an extra slice of capital.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
